Lv53
1600 积分 2024-06-18 加入
CDK inhibitors from past to present: A new wave of cancer therapy
16天前
已完结
THERAPEUTIC TARGETING OF AKT: STATUS AND FUTURE OPPORTUNITIES
26天前
已完结
Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis
1个月前
已完结
Elucidating Binding Selectivity in Cyclin-Dependent Kinases (CDKs) 4, 6, and 9: Development of Highly Potent and Selective CDK4/9 Inhibitors
2个月前
已完结
Mechanism of Two Classes of Cancer Mutations in the Phosphoinositide 3-Kinase Catalytic Subunit
2个月前
已完结
Genetic interactions reveal distinct biological and therapeutic implications in breast cancer
2个月前
已完结
Chromoanagenesis Is Frequently Associated With Highly Complex Karyotypes, Extensive Clonal Heterogeneity, and Treatment Refractoriness in Acute Myeloid Leukemia
2个月前
已完结
Phase Ib Study of Ribociclib plus Fulvestrant and Ribociclib plus Fulvestrant plus PI3K Inhibitor (Alpelisib or Buparlisib) for HR+ Advanced Breast Cancer
2个月前
已完结
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
2个月前
已完结
Endometrial cancer: an update on diagnosis, treatment and the role of molecular profiling
2个月前
已完结
皖公网安备34019202002308
